医学
少年
干细胞
全身疗法
干细胞疗法
细胞疗法
重症监护医学
内科学
移植
遗传学
生物
癌症
乳腺癌
作者
Ivan Foeldvari,Kathryn S. Torok,Juliana Silva,Christopher P. Denton,Jörg Henes,Paulina Horvei,Rosser Franziska,Catherine H. Orteu,Suzanne C. Li,Clare Pain,Tamás Constantin,Patrícia Costa‐Reis,Megan L. Curran,Maurizio Cutolo,Bernd Hinrichs,Kim Fliglstone,Susan Maillard,Pia Moinzadeh,Clarissa Pilkington,Linda Schraven
标识
DOI:10.1080/1744666x.2025.2474216
摘要
HSCT and CT hold promise as treatment options for jSSc. Our proposed guidance aims to standardize inclusion criteria globally, enhancing comparability of outcomes across future procedures. Establishing consistent inclusion/exclusion criteria and transplant protocols will enable better data collection, interpretation, and ultimately improve outcomes and care for jSSc patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI